These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9202504)

  • 1. General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow.
    Gruer L; Wilson P; Scott R; Elliott L; Macleod J; Harden K; Forrester E; Hinshelwood S; McNulty H; Silk P
    BMJ; 1997 Jun; 314(7096):1730-5. PubMed ID: 9202504
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme.
    Hutchinson SJ; Taylor A; Gruer L; Barr C; Mills C; Elliott L; Goldberg DJ; Scott R; Gilchrist G
    Addiction; 2000 Jul; 95(7):1055-68. PubMed ID: 10962770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of opiate dependent drug misusers. Glasgow model should be replicated in other general practices.
    Byrne A
    BMJ; 1997 Sep; 315(7108):602-3. PubMed ID: 9302968
    [No Abstract]   [Full Text] [Related]  

  • 5. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.
    Weinrich M; Stuart M
    JAMA; 2000 Mar; 283(10):1343-8. PubMed ID: 10714738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for opioid dependence: quality and access.
    Rounsaville BJ; Kosten TR
    JAMA; 2000 Mar; 283(10):1337-9. PubMed ID: 10714736
    [No Abstract]   [Full Text] [Related]  

  • 7. [Accompanying patients in substitution treatment for opiates: consulting and coaching in the office]].
    De Wulf I; Duquet N; Saevels J; Puttemans MK; Allard L; Bogaert J; Brohée JP; Karadag EN; Lagrain J; Ledoux MY; Remy C; Verrando R; ;
    J Pharm Belg; 2009 Mar; (1):Suppl 1-20. PubMed ID: 19396968
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of time and money prices on treatment attendance for methadone maintenance clients.
    Borisova NN; Goodman AC
    J Subst Abuse Treat; 2004 Jan; 26(1):345-52. PubMed ID: 14698798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is methadone therapy inexpensive?].
    Volfing B
    Ugeskr Laeger; 2002 Oct; 164(41):4827. PubMed ID: 12407897
    [No Abstract]   [Full Text] [Related]  

  • 10. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
    Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J
    Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for patients with opioid dependence.
    Bunker J; Winstock A; Zwar NA
    Aust Fam Physician; 2008; 37(1-2):57-60. PubMed ID: 18239755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance treatment. Glasgow has an innovative scheme for encouraging GPs to manage drug misusers.
    Scott RT; Gruer LD; Wilson P; Wood SH
    BMJ; 1995 Feb; 310(6977):464-5. PubMed ID: 7873962
    [No Abstract]   [Full Text] [Related]  

  • 13. Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian.
    Peters AD; Reid MM
    Drug Alcohol Depend; 1998 Mar; 50(1):47-55. PubMed ID: 9589272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up.
    Gossop M; Stewart D; Browne N; Marsden J
    J Subst Abuse Treat; 2003 Jun; 24(4):313-21. PubMed ID: 12867205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.
    Barnett PG; Masson CL; Sorensen JL; Wong W; Hall S
    Addiction; 2006 Dec; 101(12):1797-804. PubMed ID: 17156179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance.
    Kell MJ; Techman TM
    JAMA; 1988 Nov; 260(19):2835-6. PubMed ID: 3184345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.